Lupin Research Park stands in Pune, India. Lupin, which gets almost 30 percent of its local revenue from drugs to cure infections, is turning to skin treatments in a country where more than half the population is below the age of 35, to help lift margins. Source: Lupin Ltd. via Bloomberg